latest news in companies
Shell's Profits Double to $6.9 Billion as Middle East Conflict Drives Up Global Oil Prices
London, Friday, 8 May 2026.
Shell’s first-quarter profits for 2026 more than doubled to $6.9 billion. This massive financial windfall was driven by surging global oil prices triggered by the ongoing U.S.-Iran conflict.
SMX Transforms Recycled Plastic into Tradable Assets to Counter Volatile Material Costs
New York, Thursday, 7 May 2026.
By embedding invisible molecular markers into recycled plastics, SMX transforms supply chain waste into verifiable, tradable digital assets, helping manufacturers combat the soaring costs of virgin materials.
Shareholder Deadlines Loom for Securities Fraud Claims Against Driven Brands and Power Solutions
Los Angeles, Thursday, 7 May 2026.
Following massive stock drops tied to alleged financial misrepresentations, investors in Driven Brands and Power Solutions face urgent May 2026 deadlines to join pending securities fraud lawsuits.
Primerica Surpasses First-Quarter Expectations as Middle-Class Investments Surge 22%
Duluth, Thursday, 7 May 2026.
Despite inflation straining middle-income households, Primerica beat first-quarter estimates on May 6, driven by an impressive 22% surge in investment and savings product sales to $4.3 billion.
TOMI Environmental Solutions Targets $15 Billion Nuclear Market With $120 Million Merger
New York, Thursday, 7 May 2026.
TOMI Environmental Solutions is leveraging a $120 million merger with Carbonium Core to strategically enter the rapidly expanding $15 billion supply chain for advanced nuclear reactors.
How LinkedIn is Expanding Premium Subscriptions Through a New Global Bundling Partnership
Cambridge, Thursday, 7 May 2026.
On May 7, 2026, LinkedIn partnered with Bango to let telecom providers and banks bundle Premium subscriptions, highlighting a strategic shift toward indirect channels for acquiring new users.
Catalyst Pharmaceuticals Secures Flagship Drug Exclusivity Until 2035 Following Legal Settlement
Coral Gables, Thursday, 7 May 2026.
By settling its patent dispute with Hetero Labs, Catalyst Pharmaceuticals secures market exclusivity for its flagship drug until 2035, guaranteeing vital long-term revenue visibility for investors.
Institutional Funds Cash Out of Winning Stocks While Company Insiders Buy In
New York, Thursday, 7 May 2026.
While institutional investors take profits following a 25 percent rally in growth funds, company insiders are actively buying shares, signaling a fascinating divergence in market confidence and strategy.